| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 10.0 mg/kg/injection | 109.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 89.0 | Antitumor endpoint evaluated on day 30; 07/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 20.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 40.0 mg/kg/injection | 102.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 80.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 160.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 30; 05/08 animals surviving on day 5 |
| Q01DX005 (ip) | mean survival time | alkali diluted with saline | 160.0 mg/kg/injection | 97.0 | Antitumor endpoint evaluated on day 30; 08/08 animals surviving on day 5 |